Figure 6From: Ex vivo exposure of bone marrow from chronic kidney disease donor rats to pravastatin limits renal damage in recipient rats with chronic kidney diseaseEffects of systemic in vivo exposure to pravastatin on longitudinal variables in chronic kidney disease recipients. (A) Systolic blood pressure. (B) Urea. (C) Hematocrit. (D) Proteinuria. SNX, subtotal nephrectomy.Back to article page